Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Pulmonx Corp (LUNG)
Pulmonx Corp (LUNG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 414,109
  • Shares Outstanding, K 38,308
  • Annual Sales, $ 53,660 K
  • Annual Income, $ -58,920 K
  • 60-Month Beta 0.72
  • Price/Sales 6.62
  • Price/Cash Flow N/A
  • Price/Book 3.59
Trade LUNG with:

Options Overview Details

View History
  • Implied Volatility 64.43% ( -4.84%)
  • Historical Volatility 71.62%
  • IV Percentile 36%
  • IV Rank 36.91%
  • IV High 90.97% on 10/27/23
  • IV Low 48.90% on 11/21/23
  • Put/Call Vol Ratio 2.33
  • Today's Volume 10
  • Volume Avg (30-Day) 80
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 1,253
  • Open Int (30-Day) 330

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.43
  • Number of Estimates 2
  • High Estimate -0.41
  • Low Estimate -0.45
  • Prior Year -0.42
  • Growth Rate Est. (year over year) -2.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.56 +2.37%
on 02/23/24
14.84 -27.13%
on 02/15/24
-2.71 (-20.04%)
since 01/23/24
3-Month
10.30 +4.95%
on 12/01/23
14.84 -27.13%
on 02/15/24
+0.21 (+1.98%)
since 11/22/23
52-Week
7.75 +39.48%
on 10/13/23
14.84 -27.13%
on 02/15/24
+0.28 (+2.66%)
since 02/23/23

Most Recent Stories

More News
Pulmonx to Report First Quarter 2023 Financial Results on May 2, 2023

Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the first quarter of 2023...

LUNG : 10.81 (-8.85%)
Stocks Edge Higher on Positive Corporate News and Lower Bond Yields

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.31%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.22%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.74%....

$SPX : 5,088.80 (+0.03%)
SPY : 507.85 (+0.07%)
$DOWI : 39,131.53 (+0.16%)
DIA : 391.28 (+0.19%)
$IUXX : 17,937.61 (-0.37%)
QQQ : 436.78 (-0.29%)
UNP : 256.91 (+0.94%)
SGEN : 228.74 (-0.07%)
ALB : 120.65 (+2.09%)
PXD : 232.48 (-0.62%)
UVE : 21.09 (+22.40%)
LUNG : 10.81 (-8.85%)
Stocks Climb on Increased M&A Activity and Lower Bond Yields

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +1.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.01%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.31%. U.S. stock...

$SPX : 5,088.80 (+0.03%)
SPY : 507.85 (+0.07%)
$DOWI : 39,131.53 (+0.16%)
DIA : 391.28 (+0.19%)
$IUXX : 17,937.61 (-0.37%)
QQQ : 436.78 (-0.29%)
UNP : 256.91 (+0.94%)
SGEN : 228.74 (-0.07%)
NFLX : 583.56 (-0.83%)
ALB : 120.65 (+2.09%)
UVE : 21.09 (+22.40%)
FYBR : 22.13 (+2.31%)
Markets Today: Stock Indexes Push Higher on M&A Activity

Morning Markets March S&P 500 futures (ESH2 3) this morning are up +0.74%, and March Nasdaq 100 E-Mini futures (NQH2 3) are up +0.90%. U.S. stock index futures this morning are trading higher on increased...

ESH24 : 5,093.25 (-0.16%)
NQH24 : 17,960.75 (-0.17%)
SGEN : 228.74 (-0.07%)
UNP : 256.91 (+0.94%)
PAYO : 5.49 (+3.00%)
FOCS : 52.99 (-0.02%)
XPEV : 8.63 (-5.58%)
LUNG : 10.81 (-8.85%)
UVE : 21.09 (+22.40%)
FYBR : 22.13 (+2.31%)
TGNA : 14.20 (-2.14%)
BBY : 76.28 (+1.42%)
Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates

Pulmonx Corporation (LUNG) delivered earnings and revenue surprises of 7.32% and 11.27%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

LUNG : 10.81 (-8.85%)
SENS : 0.7300 (+5.04%)
American Lung Association Campaign Shines Spotlight on Endobronchial Valves for Advanced COPD/Emphysema

Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, has partnered with American Lung Association to provide education to patients...

LUNG : 10.81 (-8.85%)
Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema

Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW)...

LUNG : 10.81 (-8.85%)
Why Pulmonx Stock Is Crashing Today

Investors are reacting negatively to the company's planned securities offering.

LUNG : 10.81 (-8.85%)
Pulmonx Corporation (LUNG) Reports Q3 Loss, Misses Revenue Estimates

Pulmonx Corporation (LUNG) delivered earnings and revenue surprises of 5% and 9.42%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

LUNG : 10.81 (-8.85%)
HIMS : 9.52 (+0.74%)
3 Medical Info System Stocks to Gain on Rising Demand for Digital Health

Zacks Medical Info Systems industry stocks like Inspire Medical Systems, Inc. (INSP), Axonics (AXNX), and Pulmonx Corporation (LUNG) are expected to gain on rising demand for telehealth.

INSP : 184.94 (-0.44%)
AXNX : 68.39 (+0.38%)
LUNG : 10.81 (-8.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California.

See More

Key Turning Points

3rd Resistance Point 12.67
2nd Resistance Point 12.20
1st Resistance Point 11.50
Last Price 10.81
1st Support Level 10.34
2nd Support Level 9.87
3rd Support Level 9.17

See More

52-Week High 14.84
Fibonacci 61.8% 12.13
Fibonacci 50% 11.29
Last Price 10.81
Fibonacci 38.2% 10.46
52-Week Low 7.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar